05/03/2024 7:00 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/03/2024 7:05 AM | Budur Kumar (Reporting) Harmony Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024 6:45 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 8:44 AM | Harmony Biosciences (Filer)
| Form ARS | |
04/11/2024 7:30 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 7:17 AM | Harmony Biosciences (Filer)
| Form DEF 14A | |
|
04/11/2024 7:18 AM | Harmony Biosciences (Filer)
| Form DEFA14A | |
03/18/2024 6:24 PM | Dierks Jeffrey (Reporting) Harmony Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:24 PM | Dierks Jeffrey (Reporting) Harmony Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 4:17 PM | Dierks Jeffrey (Reporting) Harmony Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 3:21 PM | Dierks Jeffrey (Reporting) Harmony Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 4:16 PM | Harmony Biosciences (Filer)
| Form 10-K/A | |
02/22/2024 7:00 AM | Harmony Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/22/2024 6:45 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 6:06 PM | Harmony Biosciences (Subject) Valor IV Pharma Holdings, LLC (Filed by)
| Form SC 13G/A | |
01/24/2024 1:27 PM | BlackRock Inc. (Filed by) Harmony Biosciences (Subject)
| Form SC 13G/A | |
01/08/2024 7:30 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 7:59 AM | Anastasiou Peter (Reporting) Harmony Biosciences (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/08/2023 8:03 AM | Anastasiou Peter (Reporting) Harmony Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 7:30 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/31/2023 7:00 AM | Harmony Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/31/2023 6:45 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/13/2023 7:15 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2023 7:31 AM | Harmony Biosciences (Filed by) Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T/A | |
10/11/2023 7:15 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 1:34 PM | BlackRock Inc. (Filed by) Harmony Biosciences (Subject)
| Form SC 13G/A | |
10/05/2023 3:15 PM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/05/2023 3:15 PM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 7:00 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/27/2023 7:12 AM | Harmony Biosciences (Filed by) Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T/A | |
09/25/2023 7:00 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/14/2023 3:59 PM | Harmony Biosciences (Filed by) Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T/A | |
09/14/2023 3:42 PM | Harmony Biosciences (Filer)
| Form 8-K/A | |
08/28/2023 7:23 AM | Harmony Biosciences (Filed by) Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-T | |
08/24/2023 4:23 PM | Harmony Biosciences (Filed by) Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC 13D | |
08/14/2023 4:26 PM | Harmony Biosciences (Filed by) Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-C | |
08/14/2023 4:27 PM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 4:29 PM | Harmony Biosciences (Filed by) Zynerba Pharmaceuticals, Inc. (Subject)
| Form SC TO-C | |
08/01/2023 7:01 AM | Harmony Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023 6:45 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (Ad) While gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk.
As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires.
And it's all thanks to Musk's latest AI creation. Click to watch this device in action |
07/27/2023 7:30 AM | Harmony Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2023 3:37 PM | Dayno Jeffrey M. (Reporting) Harmony Biosciences (Issuer)
| Form 4/A | |
05/26/2023 4:25 PM | Harmony Biosciences (Issuer) Nielsen Jack (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 3:20 PM | Gracias Antonio J. (Reporting) Harmony Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 3:26 PM | Harmony Biosciences (Issuer) Sabater Juan A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |